ImportRefusal LogoImportRefusal

KDC/ONE Development Corporation, Inc.

⚠️ High Risk

FEI: 3003690512 • Knowlton, Quebec • CANADA

FEI

FEI Number

3003690512

📍

Location

Knowlton, Quebec

🇨🇦

Country

CANADA
🏢

Address

315 Knowlton Road, , Knowlton, Quebec, Canada

High Risk

FDA Import Risk Assessment

64.1
LowModerateHighCritical

This firm has a significant history of FDA import refusals with notable violations.

Statistics

30
Total Refusals
10
Unique Violations
11/21/2025
Latest Refusal
10/24/2001
Earliest Refusal

Score Breakdown

Violation Severity
67.1×40%
Refusal Volume
55.2×30%
Recency
97.1×20%
Frequency
12.4×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

7513×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

11813×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

3102×

POISONOUS

The article is subject to refusal of admission pursuant Section 801(a)(3) in that The cosmetic appears to bear or contain a poisonous or deleterious substance which may render it injurious to users under the conditions prescribed in the labeling thereof, or, under such conditions of use as are customary or usual.

32802×

FRNMFGREG

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded as defined in section 502(o) of the FD&C Act. It appears that it was manufactured, prepared, propagated, compounded, or processed in an establishment not duly registered under section 510 of the Act.

162×

DIRECTIONS

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it is a device whose label appears to not bear adequate directions for use.

4832×

DRUG NAME

The article appears to be a drug and fails to bear the proprietary or established name and/or name and quantity of each active ingredient.

4731×

LABELING

The article appears in violation of FPLA because of its placement, form and/or contents statement.

4751×

COSMETLBLG

It appears that the cosmetic consists of two or more ingredients and the label does not list the common or usual name of each ingredient.

2181×

LIST INGRE

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(i)(2) of the FD&C Act in that it is fabricated from two or more ingredients and the label fails to bear the common or usual name of each such ingredient and/or the article purports to be a beverage containing vegetable or fruit juice, but does not bear a statement with appropriate prominence on the information panel of the total percentage of such fruit or vegetable juice contained in the food.

1151×

DR QUALITY

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the article appears to be represented as a drug the name of which is recognized in an official compendium and its strength appears to differ from or its quality or purity appear to fall below the standards set forth in such compendium.

Refusal History

DateProductViolationsDivision
11/21/2025
62MBQ08MENTHOL (ANTI-PRURITIC)
75UNAPPROVED
Division of Southeast Imports (DSEI)
7/13/2021
64ABK99DISINFECTANT N.E.C.
75UNAPPROVED
Division of Southeast Imports (DSEI)
9/2/2020
62HAL05ETHYL ALCOHOL (ANTI-MICROBIAL)
75UNAPPROVED
Division of Southeast Imports (DSEI)
8/27/2020
66VAY99MISCELLANEOUS PATENT MEDICINES, ETC.
118NOT LISTED
3280FRNMFGREG
Division of Southeast Imports (DSEI)
11/25/2019
62WBY99ASTRINGENT/ANTI-PERSPIRANT N.E.C.
118NOT LISTED
3280FRNMFGREG
Division of Northern Border Imports (DNBI)
3/23/2016
53LD10WRINKLE SMOOTHING (SKIN CARE PREPARATIONS)
218LIST INGRE
Cincinnati District Office (CIN-DO)
9/24/2015
53LD10WRINKLE SMOOTHING (SKIN CARE PREPARATIONS)
75UNAPPROVED
New York District Office (NYK-DO)
9/24/2015
53LD10WRINKLE SMOOTHING (SKIN CARE PREPARATIONS)
75UNAPPROVED
New York District Office (NYK-DO)
9/24/2015
53LD10WRINKLE SMOOTHING (SKIN CARE PREPARATIONS)
75UNAPPROVED
New York District Office (NYK-DO)
9/24/2015
53LD10WRINKLE SMOOTHING (SKIN CARE PREPARATIONS)
75UNAPPROVED
New York District Office (NYK-DO)
9/24/2015
53LD10WRINKLE SMOOTHING (SKIN CARE PREPARATIONS)
75UNAPPROVED
New York District Office (NYK-DO)
9/24/2015
53LD10WRINKLE SMOOTHING (SKIN CARE PREPARATIONS)
75UNAPPROVED
New York District Office (NYK-DO)
9/24/2015
53LD10WRINKLE SMOOTHING (SKIN CARE PREPARATIONS)
75UNAPPROVED
New York District Office (NYK-DO)
4/8/2015
66PBJ99ULTRAVIOLET SCREEN/SUNSCREEN N.E.C.
118NOT LISTED
New York District Office (NYK-DO)
4/8/2015
66PBJ99ULTRAVIOLET SCREEN/SUNSCREEN N.E.C.
118NOT LISTED
New York District Office (NYK-DO)
2/10/2014
62WBY99ASTRINGENT/ANTI-PERSPIRANT N.E.C.
118NOT LISTED
Detroit District Office (DET-DO)
5/3/2012
53LY01CLEANSING (COLD CREAMS, CLEANSING LOTIONS, LIQUIDS, PADS) (SKIN CARE PREPARATIONS)
310POISONOUS
New York District Office (NYK-DO)
2/16/2012
62WBK99ASTRINGENT/ANTI-PERSPIRANT N.E.C.
118NOT LISTED
New York District Office (NYK-DO)
1/30/2012
65LBJ99PROTECTANT N.E.C.
118NOT LISTED
New York District Office (NYK-DO)
1/17/2012
53AD02LOTIONS, OILS, POWDERS AND CREAMS (BABY PRODUCTS)
310POISONOUS
New York District Office (NYK-DO)
6/1/2011
62WBY99ASTRINGENT/ANTI-PERSPIRANT N.E.C.
118NOT LISTED
Detroit District Office (DET-DO)
6/1/2011
62WBL99ASTRINGENT/ANTI-PERSPIRANT N.E.C.
118NOT LISTED
Detroit District Office (DET-DO)
5/26/2011
62WBL99ASTRINGENT/ANTI-PERSPIRANT N.E.C.
118NOT LISTED
Detroit District Office (DET-DO)
8/31/2010
62MBL08MENTHOL (ANTI-PRURITIC)
16DIRECTIONS
483DRUG NAME
75UNAPPROVED
New York District Office (NYK-DO)
8/31/2010
62MBL08MENTHOL (ANTI-PRURITIC)
16DIRECTIONS
483DRUG NAME
75UNAPPROVED
New York District Office (NYK-DO)
3/28/2008
66VBJ99MISCELLANEOUS PATENT MEDICINES, ETC.
118NOT LISTED
75UNAPPROVED
New York District Office (NYK-DO)
11/16/2007
66VBJ99MISCELLANEOUS PATENT MEDICINES, ETC.
118NOT LISTED
New York District Office (NYK-DO)
11/16/2007
66VBJ99MISCELLANEOUS PATENT MEDICINES, ETC.
118NOT LISTED
New York District Office (NYK-DO)
9/21/2004
53JG02DEODORANTS (UNDERARM)(NOT ANTIPERSPIRANT) (PERSONAL CLEANLINESS)
473LABELING
475COSMETLBLG
New England District Office (NWE-DO)
10/24/2001
60QCS64DYCLONINE HCL (ANESTHETIC)
115DR QUALITY
New York District Office (NYK-DO)

Frequently Asked Questions

What is KDC/ONE Development Corporation, Inc.'s FDA import refusal history?

KDC/ONE Development Corporation, Inc. (FEI: 3003690512) has 30 FDA import refusal record(s) in our database, spanning from 10/24/2001 to 11/21/2025.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. KDC/ONE Development Corporation, Inc.'s FEI number is 3003690512.

What types of violations has KDC/ONE Development Corporation, Inc. received?

KDC/ONE Development Corporation, Inc. has been cited for 10 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about KDC/ONE Development Corporation, Inc. come from?

All FDA import refusal data for KDC/ONE Development Corporation, Inc. is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.